4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-039323
Options or other derivatives
- Director acquired 124,000 shares (grant or award)
From the SEC's structured data for this filing
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-039323
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…